THE FOLLOWING ARE EXAMPLES OF SUBSTANCES THAT MAY INCREASE THE BLOOD-GLUCOSE-LOWERING EFFECT AND SUSCEPTIBILITY TO HYPOGLYCEMIA: ORAL ANTIDIABETIC PRODUCTS, ACE INHIBITORS, DISOPYRAMIDE, FIBRATES, FLUOXETINE, MONOAMINE OXIDASE (MAO) INHIBITORS, PROPOXYPHENE, SALICYLATES, SOMATOSTATIN ANALOG (E.G. OCTREOTIDE), SULFONAMIDE ANTIBIOTICS.
THE FOLLOWING ARE EXAMPLES OF SUBSTANCES THAT MAY REDUCE THE BLOOD-GLUCOSE-LOWERING EFFECT: CORTICOSTEROIDS, NIACIN, DANAZOL, DIURETICS, SYMPATHOMIMETIC AGENTS (E.G., EPINEPHRINE, SALBUTAMOL, TERBUTALINE), ISONIAZID, PHENOTHIAZINE DERIVATIVES, SOMATROPIN, THYROID HORMONES, ESTROGENS, PROGESTOGENS (E.G., IN ORAL CONTRACEPTIVES).
BETA-BLOCKERS, CLONIDINE, LITHIUM SALTS, AND ALCOHOL MAY EITHER POTENTIATE OR WEAKEN THE BLOOD-GLUCOSE- LOWERING EFFECT OF INSULIN.
PENTAMIDINE MAY CAUSE HYPOGLYCEMIA, WHICH MAY SOMETIMES BE FOLLOWED BY HYPERGLYCEMIA.
IN ADDITION, UNDER THE INFLUENCE OF SYMPATHOLYTIC MEDICAL PRODUCTS SUCH AS BETA-BLOCKERS, CLONIDINE, GUANETHIDINE, AND RESERPINE, THE SIGNS OF HYPOGLYCEMIA MAY BE REDUCED OR ABSENT